Skip to content
sellWeak cluster of 6

Michael Charles Ferguson Hannay sold $5,735 of BCYC

CHIEF PROD & SUPPLY CHAIN OFF at BICYCLE THERAPEUTICS PLC. 733 shares at an average of $7.82, traded Apr 2, 2025, filed Apr 4, 2025.

Warning score
30
Value
$5,735
733 shares
Holdings after
54,547
-1% from before
From 52-week low
+3%
low $7.85, close $8.05
From 52-week high
-71%
high $27.51, as of Apr 2, 2025

Score components

  • Role
    Officer
    +15
  • Trade size
    $6k at market
    0
  • Share of holdings sold
    Sold 1.3% of holdings
    0
  • Cluster
    6 insiders selling within 14 days
    +15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

BCYCOct 9, 2026 · close 3.89
Since filing Apr 4, 2025: -43.5%SPY +56.6% · excess -100.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001415889-25-010241, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Apr 2, 2025SOpen-market sale
Ordinary Shares
-467$8.02$3,74554,813Apr 4, 2025
Apr 3, 2025SOpen-market sale
Ordinary Shares
-266$7.48$1,99054,547Apr 4, 2025

Related signals

Other insiders at BICYCLE THERAPEUTICS PLC and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
15Weak
BCYCsell 610b5-1
BICYCLE THERAPEUTICS PLC
Jennifer Scott Perry
Chief Operating Officer
$1,339
356 shares
-0%
30Weak
BCYCsell 6
BICYCLE THERAPEUTICS PLC
Michael Skynner
CHIEF SCIENTIFIC OFFICER
$8,534
2,445 shares
-2%
45Moderate
BCYCsell 6
BICYCLE THERAPEUTICS PLC
Kevin Lee
CHIEF EXECUTIVE OFFICER
$27k
7,805 shares
-1%
37Weak
BCYCsell 6
BICYCLE THERAPEUTICS PLC
Travis Alvin Thompson
Chief Financial Officer
$3,381
972 shares
-1%
30Weak
BCYCsell 6
BICYCLE THERAPEUTICS PLC
Michael Charles Ferguson Hannay
CHIEF PROD & SUPPLY CHAIN OFF
$6,319
1,814 shares
-2%
35Weak
BCYCsell 6
BICYCLE THERAPEUTICS PLC
Robert Charles Swanton
director
$12k
3,431 shares
-18%
15Weak
BCYCsell 610b5-1
BICYCLE THERAPEUTICS PLC
Jennifer Scott Perry
Chief Operating Officer
$5,313
1,500 shares
-2%
30Weak
BCYCsell 6
BICYCLE THERAPEUTICS PLC
Travis Alvin Thompson
CHIEF ACCOUNTING OFFICER
$2,500
319 shares
-1%
35Weak
BCYCsell 6
BICYCLE THERAPEUTICS PLC
Alistair Milnes
CHIEF OPERATING OFFICER
$17k
2,171 shares
-2%
46Moderate
BCYCsell 6
BICYCLE THERAPEUTICS PLC
Kevin Lee
CHIEF EXECUTIVE OFFICER
$44k
5,669 shares
-1%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Michael Charles Ferguson Hannay sold $5,735 of BCYC | InsiderTell